Epidiolex®, a cannabidiol (CBD) oral solution by Greenwich Biosciences, is now indicated for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS) or Tuberous Sclerosis Complex in patients one year of age or older. Read more about this development in Drug Topics.
![](https://healthcarenavigationfl.com/wp-content/uploads/2023/10/be021640-8517-0ed1-bdd5-44c8b75fdd23.jpg)